Products Imported As Supplements Contain Anticonvulsants, Cholesterol Drugs
This article was originally published in The Tan Sheet
Executive Summary
A July 15 import alert states that FDA and U.S. Customs officials can detain without physical examination certain imports from 20 foreign firms, including 14 from China.